Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06106984 · ClinicalTrials.gov registry record · NA

Home-based Rehabilitation Intervention for Phantom Limb Pain in Veterans With Lower Limb Amputations

A NA study of Phantom Limb Pain, sponsored by VA Office of Research and Development.

Recruiting
Registry status
NA
Development phase
36
Enrollment target
1
Study location

NCT06106984: Recruiting NA study of Phantom Limb Pain, sponsored by VA Office of Research and Development.

NCT06106984 is a NA study of Phantom Limb Pain that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 36 participants, below the 120-participant average among 12 other Phantom Limb Pain trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06106984, a NA study of Phantom Limb Pain, is actively recruiting participants, sponsored by VA Office of Research and Development.

RECRUITING
Registry status
NA
Development phase
36 participants
Enrollment target
1
Study location

Study Summary

Nearly 60-85% of Veterans with amputations experience pain at the location of the amputated limb called phantom limb pain (PLP). PLP is a major problem and can have a profound impact on Veteran's daily function and ability to fully participate in life. Although several rehabilitation interventions are promising, advances in novel rehabilitation interventions are limited. The objective of this project is to refine a mobile app for graded motor imagery in 12 Veterans with amputations and test the mobile app with 36 Veterans with amputations. For this pilot project, the investigators will measure the preliminary feasibility and acceptability of the intervention. Knowledge from this project will provide evidence to guide future larger studies of this graded motor imagery intervention. Developing novel strategies for chronic pain in this population will positively impact quality of life for Veterans with amputations.

Primary Outcome

The Acceptability of Intervention Measure is a measure of the acceptability of the intervention sessions and if acceptability changes over time. This measure will evaluate the acceptability of using a mobile app with a telehealth platform. Minimum score: 12, maximum score: 60. A higher score indicates greater acceptability of the intervention, a lower score indicates lower acceptability of the intervention.

Conditions Studied

Interventions

  • DEVICE Graded motor imagery mobile app

Study Locations (1)

Minnesota

  • Minneapolis VA Health Care System, Minneapolis, MN - Minneapolis

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2024-04-01
Est. Completion 2029-03-31
Phase NA
VA Office of Research and Development

1,668 total trials

What NCT06106984 shows while recruiting

NCT06106984 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 120-participant average among 12 other Phantom Limb Pain trials with a reported enrollment target (70% lower).

The record links to 1 condition, with Phantom Limb Pain appearing as the primary indexed condition, and to 1 intervention - of which Graded motor imagery mobile app is the first listed.

NCT06106984 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT06106984 about?

NCT06106984 is a clinical study titled "Home-based Rehabilitation Intervention for Phantom Limb Pain in Veterans With Lower Limb Amputations". Nearly 60-85% of Veterans with amputations experience pain at the location of the amputated limb called phantom limb pain (PLP). PLP is a major problem and can have a profound impact on Veteran's daily function and ability to fully participate in life. Although several rehabilitation interventions a...

What is the current status of trial NCT06106984?

This trial is currently recruiting. It is a NA study. The enrollment target is 36 participants. The study started on 2024-04-01. Estimated completion is 2029-03-31.

What conditions does trial NCT06106984 study?

This clinical trial studies the following conditions: Phantom Limb Pain.

What interventions are being tested in trial NCT06106984?

The interventions under investigation include: Graded motor imagery mobile app (DEVICE).

Who is sponsoring clinical trial NCT06106984?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06106984 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Phantom Limb Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06106984's enrollment target sits among peer trials

36 8th of 12 higher than 5 of 12 other Phantom Limb Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phantom Limb Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00929006 · 36 participants · Early Phase 1

    Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism

  • NCT01891318 · 36 participants · Phase 1

    Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study

  • NCT02291848 · 36 participants · Phase 1

    Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma

  • NCT02366819 · 36 participants · Phase 4

    Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06106984, the US trial registry maintained by the National Library of Medicine. NCT06106984 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.